OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9815	Companies
196895	Keywords
127961	Articles
104712	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 05/12/2025 at 18:00, 8 months 24 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease

Biopharmaceutical Shareholding Changes Ophthalmic Therapies Oxurion NV Transparency Notifications
PRESS RELEASE

published on 05/12/2025 at 18:00, 8 months 24 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelentransacties en voldoet aan Belgische transparantiewetgeving. Het biofarmaceutisch bedrijf ontwikkelt oftalmologische therapieën

Transparantiekennisgevingen Oxurion NV Oftalmologische Therapieën Belgische Transparantiewetgeving Biofarmaceutisch Bedrijf
BRIEF

published on 05/09/2025 at 18:05, 8 months 27 days ago

Oxurion Increases Capital Following Convertible Bond Conversion

Convertible Bonds Capital Increase Atlas Special Opportunities Vision Preservation Oxurion Shares
BRIEF

published on 05/09/2025 at 18:05, 8 months 27 days ago

Oxurion augmente son capital suite à la conversion d'obligations convertibles

Obligations Convertibles Augmentation De Capital Opportunités Spéciales Atlas Préservation De La Vision Actions Oxurion
PRESS RELEASE

published on 05/09/2025 at 18:00, 8 months 27 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, resulting in EUR 100,000 capital increase, supporting innovative therapeutics development for vision preservation in elderly. Oxurion shares update post-capital increase

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Vision Preservation
PRESS RELEASE

published on 05/09/2025 at 18:00, 8 months 27 days ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC converteert 4 obligaties in Oxurion, resulterend in EUR 100.000 kapitaalverhoging. Oxurion verstrekt 1.521.372 gewone aandelen. Meer info op www.oxurion.com

Kapitaalverhoging Atlas Special Opportunities Aandelen Oxurion Innovatieve Geneesmiddelen
BRIEF

published on 04/25/2025 at 18:35, 9 months 10 days ago

Oxurion Arrête une Transaction de 2024 et Continue les Négociations pour une Nouvelle Acquisition

Acquisition Négociations CRO Oxurion Biométrie
BRIEF

published on 04/25/2025 at 18:35, 9 months 10 days ago

Oxurion Stops 2024 Transaction and Continues Negotiations for New Acquisition

Acquisition Negotiations CRO Oxurion Biometrics
PRESS RELEASE

published on 04/25/2025 at 18:30, 9 months 10 days ago

Oxurion kondigt stopzetting aan van de transactie van juli 2024 en bevestigt de voortzetting van de gesprekken over het overnameproject aangekondigd in maart 2025
Oxurion NV (Euronext Brussels: OXUR) stops negotiations for majority stake acquisition in French CRO, continues talks for majority stake in CRO specializing in biometrics and advanced data management. Market updates to follow

Majority Stake Acquisition Clinical Studies CRO Oxurion NV Biometrics
PRESS RELEASE

published on 04/25/2025 at 18:30, 9 months 10 days ago

Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025
Oxurion NV halts acquisition of French CRO, pursues deal with biometrics CRO to expand capabilities in clinical data management. Progress updates to follow

Acquisition CRO Oxurion NV Clinical Data Management Biometrics

Accesswire

Published on 02/06/2026 at 00:57, 1 hour 47 minutes ago

Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 2 hours 44 minutes ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 3 hours 29 minutes ago

Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 3 hours 44 minutes ago

Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 5 hours 44 minutes ago

Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 19:27, 7 hours 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 7 hours 58 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 8 hours 35 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 8 hours 49 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 9 hours 4 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

Les Echos

Published on 02/05/2026 at 19:24, 7 hours 20 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 7 hours 20 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 7 hours 29 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 7 hours 29 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 7 hours 29 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE